HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ignace Vergote Selected Research

Adenosine Diphosphate Ribose (ADP-Ribose)

12/2019Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
12/2016Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.
4/2012Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ignace Vergote Research Topics

Disease

167Ovarian Neoplasms (Ovarian Cancer)
04/2022 - 01/2003
153Neoplasms (Cancer)
04/2022 - 01/2003
41Carcinoma (Carcinomatosis)
04/2022 - 01/2002
37Endometrial Neoplasms (Endometrial Cancer)
01/2022 - 03/2002
37Ovarian Epithelial Carcinoma
01/2022 - 02/2003
30Breast Neoplasms (Breast Cancer)
01/2021 - 05/2003
24Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2022 - 01/2002
16Disease Progression
10/2022 - 07/2003
15Ascites
03/2022 - 12/2005
10Neoplasm Metastasis (Metastasis)
11/2021 - 01/2002
10Neutropenia
01/2019 - 05/2003
8Residual Neoplasm
01/2022 - 02/2003
8Nausea
11/2021 - 05/2003
7Fatigue
01/2022 - 02/2012
7Vomiting
01/2020 - 04/2012
7Carcinogenesis
11/2019 - 03/2003
5Hypertension (High Blood Pressure)
01/2022 - 05/2014
5Vulvar Neoplasms (Vulvar Cancer)
11/2021 - 09/2008
5Fallopian Tube Neoplasms
01/2021 - 04/2016
5Anemia
12/2016 - 04/2012
5Carcinosarcoma
09/2013 - 11/2003
4Proteinuria
01/2022 - 05/2014
4Diarrhea
01/2019 - 10/2014
4Leiomyosarcoma
01/2018 - 12/2004
4Thrombocytopenia (Thrombopenia)
12/2016 - 10/2014
4Endometrioid Carcinoma
10/2015 - 12/2008
4Uterine Neoplasms (Uterine Cancer)
01/2014 - 12/2008
4Sarcoma (Soft Tissue Sarcoma)
02/2009 - 11/2003
3Chromosomal Instability (Chromosome Stability)
04/2022 - 01/2016
3Adenocarcinoma
01/2021 - 03/2007
3Peritoneal Neoplasms
11/2018 - 01/2014
3Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational)
01/2018 - 06/2012

Drug/Important Bio-Agent (IBA)

85PlatinumIBA
10/2022 - 01/2003
38Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 03/2003
34Carboplatin (JM8)FDA LinkGeneric
01/2022 - 10/2006
29Biomarkers (Surrogate Marker)IBA
03/2022 - 02/2003
16olaparibIBA
01/2022 - 02/2012
14Proteins (Proteins, Gene)FDA Link
04/2022 - 04/2009
13Progesterone Receptors (Progesterone Receptor)IBA
01/2019 - 02/2003
13Estrogen ReceptorsIBA
01/2019 - 02/2003
13Hormones (Hormone)IBA
06/2017 - 02/2003
12Bevacizumab (Avastin)FDA Link
01/2022 - 05/2014
12liposomal doxorubicin (Doxil)FDA Link
11/2021 - 07/2010
12Biological ProductsIBA
01/2016 - 03/2003
11Pharmaceutical PreparationsIBA
03/2022 - 05/2013
10Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2021 - 02/2012
10Messenger RNA (mRNA)IBA
01/2019 - 12/2006
9Estrogens (Estrogen)FDA Link
01/2018 - 06/2004
8DNA (Deoxyribonucleic Acid)IBA
04/2022 - 05/2014
7taxaneIBA
04/2022 - 07/2010
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2019 - 02/2012
7Aromatase InhibitorsIBA
02/2014 - 05/2004
61-dodecylpyridoxal (PLD)IBA
11/2021 - 07/2010
6RNA (Ribonucleic Acid)IBA
01/2021 - 02/2015
6ErbB Receptors (EGF Receptor)IBA
01/2019 - 06/2007
6TamoxifenFDA LinkGeneric
01/2018 - 11/2003
6Cisplatin (Platino)FDA LinkGeneric
03/2016 - 01/2005
5VaccinesIBA
01/2022 - 09/2010
5Immunoconjugates (Immunoconjugate)IBA
01/2022 - 07/2018
5Topotecan (Hycamtin)FDA LinkGeneric
11/2021 - 05/2003
5GemcitabineFDA Link
06/2021 - 03/2003
5ParaffinIBA
01/2021 - 12/2008
5trebananibIBA
01/2019 - 07/2014
5Folic Acid (Vitamin M)FDA LinkGeneric
07/2018 - 05/2014
5Fulvestrant (Faslodex)FDA Link
05/2008 - 07/2003
4Immune Checkpoint InhibitorsIBA
01/2022 - 01/2021
4Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2021 - 06/2016
4Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2020 - 05/2014
4mirvetuximab soravtansineIBA
01/2020 - 01/2018
4Interleukin-10 (Interleukin 10)IBA
11/2019 - 04/2014
4MicroRNAs (MicroRNA)IBA
01/2016 - 06/2011
4thiaclopridIBA
02/2015 - 08/2011
4Transcription Factors (Transcription Factor)IBA
01/2015 - 12/2008
4Anastrozole (Arimidex)FDA LinkGeneric
02/2011 - 07/2003
3Tyrosine Kinase InhibitorsIBA
01/2022 - 06/2007
3tisotumab vedotinIBA
01/2022 - 01/2020
3CytokinesIBA
11/2021 - 01/2018
3Adenosine Diphosphate Ribose (ADP-Ribose)IBA
12/2019 - 04/2012
3Adenosine Diphosphate (ADP)IBA
12/2019 - 04/2012
3InterleukinsIBA
11/2019 - 04/2016
3Transforming Growth Factors (Transforming Growth Factor)IBA
11/2019 - 04/2016
3Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
11/2019 - 04/2016
3human ERBB2 proteinIBA
01/2019 - 04/2008
3Phosphotransferases (Kinase)IBA
01/2018 - 07/2010
3EnzymesIBA
01/2018 - 02/2015

Therapy/Procedure

88Drug Therapy (Chemotherapy)
10/2022 - 01/2003
67Therapeutics
12/2021 - 05/2003
26Neoadjuvant Therapy
04/2022 - 11/2005
18Lymph Node Excision (Lymph Node Dissection)
11/2021 - 01/2002
13Immunotherapy
01/2022 - 09/2010
13Adjuvant Chemotherapy
11/2021 - 01/2003
11Cytoreduction Surgical Procedures
12/2021 - 02/2011
10Radiotherapy
11/2021 - 01/2002
10Hysterectomy
01/2021 - 03/2007
4Palliative Care (Palliative Therapy)
02/2021 - 03/2003
4Salpingo-oophorectomy
01/2020 - 01/2008
4Hyperthermic Intraperitoneal Chemotherapy
12/2019 - 01/2018
4Aftercare (After-Treatment)
03/2016 - 03/2003
3Minimally Invasive Surgical Procedures
11/2021 - 01/2016
3Conservative Treatment
01/2019 - 07/2007